A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer

Cancer Detection and Prevention

Volumn 24, Issue 3, 2000, Pages 212-223

  Pawlowski, V ^a   Revillion, F ^a   Hornez, L ^a   Peyrat, J P ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

5' nuclease assay; ErbB 2 oncogene; Fluorogenic probes; HER2 neu oncogene; Human breast cancer; MRNA expression

Indexed keywords

ASSAY; BREAST CANCER; CANCER CELL; CANCER SCREENING; CELL LINE; DISEASE DETECTION; FRANCE; HOUSEKEEPING GENE; ONCOGENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC TECHNIQUES; HUMANS; IMMUNOENZYME TECHNIQUES; MAGNESIUM CHLORIDE; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033841411     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. A v-erbB related proto-oncogene, c-erbB2, is distinct from the c-erbB1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
2. Amplification of a novel v-erbB-related gene in a human mammary carcinoma
3. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
4. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
5. The product of the human cerbB2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity
6. ERBB2 oncogene in human breast cancer and its clinical significance
7. p185 HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor
8. A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diaminedichloroplatinum against human breast and ovarian tumor cell lines
9. Antibody to HER2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells
10. Anti-HER2 humanized monoclonal antibody alone and in combination with chemotherapy against human breast carcinoma xenografts
11. Enhanced antiproliferative activity of the combination of tamoxifen plus HER-2-neu antibody
12. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu overexpressing metastatic breast cancer
13. Addition of Herceptin (humanized anti-HER2 antibody) to first line chemotherapy for her2 overexpression in metastatic breast cancer (HER2+/MBC) markedly increases anticancer activity: A randomized, multinational controlled phase III trial
14. Detection and temporal appearance of multiple copies of c-erbB-2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction
15. Critical determination of the frequency of c-erbB-2 amplification in breast cancer
16. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template
17. Competitive reverse transcriptase-PCR. An improved method for determination of c-erbB-2 gene expression
18. Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCR
19. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase
20. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
21. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms
22. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
23. Sensitivity of HER2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
24. Real time quantitative PCR
25. A novel method for real-time quantitative RT-PCR
26. Detection of bcrabl transcripts in chronic myeloid leukemia (CML) using a real-time quantitative RT-PCR assay
27. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy
28. Real-time quantitative RT-PCR after laser-assisted cell picking
29. One-step fluorescent probe product-enhanced reverse transcriptase assay
30. Quantitative determination of c-erbB-2 in human breast tumours: Potential prognostic significance of low values
31. Expression of the HER2/neu proto-oncogene in normal human adult and fetal tissues
32. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer